Breakthrough in Genetic Medicine: Cleveland Clinic Phase 1 Trial Demonstrates Lasting Cholesterol Reduction via CRISPR-Cas9
Executive Overview In what may represent a monumental turning point for cardiovascular medicine, researchers at the Cleveland Clinic have released landmark one-year data from a first-in-human Phase 1 clinical trial.…